不同胶原酶对cGVHD小鼠唾液腺免疫细胞分析的影响
该研究建立MHC不相合cGVHD小鼠模型,比较无胶原酶、Ⅱ型胶原酶和D型胶原酶消化对唾液腺免疫细胞流式分析的影响。结果显示胶原酶消化提高单个核细胞数量和活率,Ⅱ型胶原酶回收单个核细胞最多但降低CD4+ T细胞比例,D型胶原酶对CD4+ T细胞无显著影响。
要点
- 胶原酶消化显著提高唾液腺单个核细胞总数和活率。
- Ⅱ型胶原酶回收单个核细胞最多,但显著降低CD4+ T细胞比例。
- D型胶原酶更适于富集CD4+ T细胞、中性粒细胞和单核细胞。
核心结论
- 胶原酶消化显著增加单个核细胞数量和活率。
- 含Ⅱ型胶原酶方案对分离CD8+ T细胞、NK细胞和巨噬细胞最优。
- D型胶原酶更有效富集CD4+ T细胞、中性粒细胞与单核细胞。
研究设计与样本
- 构建MHC不相合小鼠模型,骨髓5×10(6)个细胞、脾0.25×10(6)个细胞。
- 设无GVHD组(BALB/c至BALB/c,n=15)和cGVHD组(C57BL/6至BALB/c,n=15)。
- 移植后第45天收集唾液腺(n=6-12),行HE和Masson染色及流式细胞术分析。
主要发现
- cGVHD组移植后第60天体重占比(66.77±11.72)%对(101.20±4.19)%,P<0.0001。
- cGVHD组症状评分2.11±0.59对0±0,P<0.0001;第60天存活率50%对100%,P=0.0011。
- cGVHD组唾液腺细胞浸润评分3.67±0.52对2.00±0,P<0.0001;纤维化面积占比(14.54±4.05)%对(4.11±0.87)%,P=0.0001。
- Ⅱ型胶原酶降低CD4+ T细胞比例(5.64±2.05)%对(31.98±12.23)%,P=0.0052;D型胶原酶无显著影响(31.51±16.37)%对(31.98±12.23)%,P=0.9973。
- Ⅱ型胶原酶降低Ly6C(low)CD11b(+)Ly6G(+)中性粒细胞比例(0.05±0.01)%对(0.34±0.20)%,P=0.0171;D型胶原酶无显著影响(0.49±0.19)%对(0.34±0.20)%,P=0.2800。
临床怎么用
- 分析唾液腺CD8+ T细胞、NK细胞和巨噬细胞时优先选用含Ⅱ型胶原酶方案。
- 分析唾液腺CD4+ T细胞、中性粒细胞和单核细胞时优先选用含D型胶原酶方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To preliminarily explore the influence of different collagenases on the analysis of immune cells in salivary glands of mice with chronic graft-versus-host disease (cGVHD) . Methods: A major histocompatibility complex mismatch model was established (bone marrow: 5×10(6) cells; spleen: 0.25×10(6) cells), including the non-graft-versus-host disease (GVHD) control group (BALB/c to BALB/c, n=15) and cGVHD group (C57BL/6c to BALB/c, n=15). Body weight, clinical scores, and survival rates of the mice were observed after transplantation. On day 45 after transplantation, salivary glands were collected (n=6-12), and hematoxylin and eosin and Masson trichrome staining were performed to assess the degree of injury and fibrosis. Flow cytometry analysis was conducted to compare immune cell populations and phenotypes among samples without collagenase digestion, with collagenase Ⅱ digestion, and with collagenase D digestion. Results: Compared with the non-GVHD group, mice in the cGVHD group showed significant weight loss [original body weight percentage on day 60 after transplantation: (66.77±11.72) % vs (101.20±4.19) %, P<0.0001], higher symptom scores (2.11±0.59 vs 0±0, P<0.0001), and significantly lower survival rates (survival rate on day 60 after transplantation: 50% vs 100%, P=0.0011). The salivary glands of cGVHD mice showed acinar atrophy, cellular infiltration (3.67±0.52 vs 2.00±0, P<0.0001), and fibrosis [ (14.54±4.05) % vs (4.11±0.87) %, P=0.0001]. Collagenase digestion significantly increased the yield and viability of mononuclear cells (P<0.05). Among the tested protocols, digestion with collagenase Ⅱ resulted in the greatest recovery of mononuclear cells (P<0.01). However, collagenaseⅡdigestion significantly reduced the proportion of CD4(+) T cells [ (5.64±2.05) % vs (31.98±12.23) %, P=0.0052], whereas collagenase D had no significant effect on CD4(+) T cells[ (31.51±16.37) % vs (31.98±12.23) %, P=0.9973]. In the cGVHD group, the method containing collagenase D recovered more CD4(+) T cells, whereas the method containing collagenase Ⅱ recovered more CD8(+) T cells (all P value<0.05). In addition, the number of natural killer (NK) cells was significantly increased in both groups after collagenase digestion (all P value<0.05). Among myeloid cells, collagenaseⅡdigestion significantly reduced the proportion of Ly6C(low)CD11b(+)Ly6G(+) neutrophils [ (0.05±0.01) % vs (0.34±0.20) %, P=0.0171], whereas collagenase D had no significant effect [ (0.49±0.19) % vs (0.34±0.20) %, P=0.2800]. In cGVHD tissues, the number of CD11b(+)Ly6C(+)Ly6G(-) monocytes rcovered with collagenase D digestion was significantly higher than that recovered with collagenase Ⅱ digestion [ (0.06±0.05) ×10(5) vs (0.01±0) ×10(5), P=0.0384], whereas the number of macrophages rcovered with collagenase Ⅱ digestion was significantly higher than that recovered with collagenase D digestion [ (1.42±0.56) ×10(5) vs (0.57±0.36) ×10(5), P<0.0001]. Conclusion: Collagenase digestion significantly increased the number and viability of mononuclear cells. The method containing collagenase Ⅱ yielded the highest number of mononuclear cells as well as CD8(+) T cells, NK cells, and macrophages, whereas collagenase D was more suitable for recovering CD4(+) T cells, neutrophils, and monocytes. 目的: 初步探讨不同胶原酶对慢性移植物抗宿主病(cGVHD)小鼠唾液腺免疫细胞分析的影响。 方法: 构建主要组织相容性复合体不相合小鼠模型(骨髓:5×10(6)个细胞;脾:0.25×10(6)个细胞),包括无GVHD组(BALB/c小鼠供BALB/c小鼠,15只)和cGVHD组(C57BL/6小鼠供BALB/c小鼠,15只),移植后观察小鼠体重、症状评分和生存率。在移植后第45天,收集各组小鼠的唾液腺(6~12只),进行HE和Masson三色染色评估损伤及纤维化程度;通过流式细胞术分析,比较无胶原酶消化、Ⅱ型胶原酶消化和D型胶原酶消化对免疫细胞表型的影响。 结果: 与无GVHD组相比,cGVHD组小鼠移植后体重下降[移植后第60天初始体重占比:(66.77±11.72)%对(101.20±4.19)%,P<0.0001],症状评分高(2.11±0.59对0±0,P<0.0001),存活率降低[移植后第60天存活率:50%对100%,P=0.0011]。cGVHD小鼠唾液腺表现为腺泡结构萎缩,细胞浸润(病理评分:3.67±0.52对2.00±0,P<0.0001)和明显纤维化[胶原纤维面积占比:(14.54±4.05)%对(4.11±0.87)%,P=0.0001]。使用胶原酶消化的方法显著增加了单个核细胞的总数和活率(P值均<0.05),其中含Ⅱ型胶原酶方案获得的单个核细胞数量最高(P<0.01)。但是Ⅱ型胶原酶消化降低了CD4(+) T细胞比例[(5.64±2.05)%对(31.98±12.23)%,P=0.0052],而D型胶原酶对CD4(+) T细胞无明显影响[(31.51±16.37)%对(31.98±12.23)%,P=0.9973]。cGVHD组中,含D型胶原酶方案能够获得更多CD4(+) T细胞而含Ⅱ型胶原酶方案能够获得更多CD8(+)T细胞(P值均<0.05)。NK细胞数量在两种胶原酶处理下均显著增加(P值均<0.05)。在髓系细胞中,Ⅱ型胶原酶降低Ly6C(low)CD11b(+)Ly6G(+)中性粒细胞比例[(0.05±0.01)%对(0.34±0.20)%,P=0.0171],D型胶原酶无影响[(0.49±0.19)%对(0.34±0.20)%,P=0.2800]。在cGVHD组中,D型胶原酶处理后获得的CD11b(+)Ly6C(+)Ly6G(-)单核细胞数量高于Ⅱ型胶原酶[(0.06±0.05)×10(5)对(0.01±0)×10(5),P=0.0384],而Ⅱ型胶原酶处理后获得的巨噬细胞数量明显高于D型胶原酶[(1.42±0.56)×10(5)对(0.57±0.36)×10(5),P<0.0001]。 结论: 使用胶原酶消化显著增加了单个核细胞的数量和活率。其中含Ⅱ型胶原酶方案对分离CD8(+) T细胞、NK细胞和巨噬细胞最优;D型胶原酶则更有效地富集CD4(+)T细胞、中性粒细胞与单核细胞。.
引用
- Hu ZY, Song QX, Yang SJ, et al. [The influence of different collagenases on the analysis of immune cells in salivary glands of mice with chronic graft-versus-host disease]. Zhonghua Xue Ye Xue Za Zhi. 2026. PMID: 41991311. doi:10.3760/cma.j.cn121090-20260122-00048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。